Startup profile · funding coverage
Evvy funding, valuation and investors
At-home CLIA/CLEP mNGS vaginal microbiome tests plus clinician-guided care.
Verified company research · funding, investors and latest developments
Keep track of Evvy
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series B
$40M · September 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$40M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series b · New York, New York, USA
Investors in latest funding
Lead: Catalio Capital Management
Other: Alumni Ventures , Rethink Impact , Muse Capital
Overview
Evvy (founded 2021 by Priyanka Jain, Laine Bruzek, and Pita Navarro) offers at-home vaginal microbiome testing with mNGS sequencing, clinician review, and personalized care pathways. The company says it has served more than 100,000 patients and about 3,000 practitioners in the U.S. Series B: $40 million led by Catalio Capital Management on September 15, 2026.
Why Evvy is interesting
On Sep 15, 2026 Evvy raised a $40M Series B led by Catalio on a company-claimed 100,000+ patient dataset — expanding from vaginal health into fertility research without disclosing valuation.
Product & use cases
Mail-in vaginal microbiome mNGS test with clinician interpretation, portal results, optional prescription pathways, and EvvyAI guidance layered on the dataset.
- At-home vaginal microbiome testing with clinician review
- Personalized treatment pathways for infections and related symptoms
- Research linking microbiome biology to fertility outcomes
Key facts
- $40M Series B led by Catalio Capital Management (Sep 15, 2026)
- >100,000 patients and ~3,000 practitioners claimed (TechCrunch)
- Expanding research toward fertility / IVF-adjacent microbiome links
Funding history (newest first)
Series B
2026-09 $40M- Catalio Capital Management (lead)
- Alumni Ventures (participant)
- Rethink Impact (participant)
- Muse Capital (participant)
Source: Read source · mobihealthnews.com
Investors in our directory
Funds linked from Evvy's profile — open a fund page for stage focus and related deal articles.
Market / IPO context
Editorial / static context — not a live quote.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.